Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male

NCT00582543 2011-10-17

MRI/MRSI in Risk Assessment of Prostate Cancer Patients

Phase NA Completed

357 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

SIB

Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

OLIGOPELVIS2

FAST-ONE

JUMP

IP4-CHRONOS

PRIS

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

Adjuvant Hypofractionated Radiotherapy for Prostate Cancer

HypoF-SBRT

Tumor TARGET Prostate Cancer

ENFORCE

Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer

ProtoChoice-P

Low Dose Hemi-body Radiation For Recurrent Prostate Cancer

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

SPCG-15

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer

Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer

Proton Therapy for High Risk Prostate Cancer

PROGERAD

Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

MRI/MRSI in Risk Assessment of Prostate Cancer Patients